EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Amino acid and protein Sources: 6

Taurine

Also called: 2-aminoethanesulfonic acid

Taurine (2-aminoethanesulfonic acid) is a sulfur-containing amino acid. It is an ingredient commonly used in some energy drinks, and Health Canada has a monograph for it as an oral natural health product.

Category
Amino acid and protein
Forms
Taurine (oral)
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2024 meta-analysis (Nutrition Journal) pooled 20 placebo-controlled RCTs (808 participants) of taurine for cardiovascular measures; in at least 14, the treatment arm was taurine capsules, tablets or a taurine sachet. [3]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Taurine does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Taurine, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood glucose, lipids and other cardiometabolic risk factorsBA 2026 meta-analysis of 34 RCTs found oral taurine lowered fasting glucose (−5.90 mg/dL), HbA1c, triglycerides, total and LDL cholesterol, and systolic pressure (−4.38 mmHg); 1.5–3.0 g/day appeared more effective. [2]
Heart rate, blood pressure and heart functionBA 2024 meta-analysis of 20 RCTs (808 participants) reported lower heart rate (−3.579 bpm) and systolic pressure (−3.999 mm Hg), and higher LVEF in heart failure; no significant adverse effects versus controls. [3]
Cognitive functionCA 2025 meta-analysis of 7 RCTs (402 individuals) found taurine, alone or with exercise training, had no significant effect on cognitive scores; the authors found insufficient evidence of benefit. [4]

Main constituents: Taurine (proper name 2-aminoethanesulfonic acid) [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • In the 2026 cardiometabolic meta-analysis, 1.5–3.0 g/day appeared more effective; interventions of 8 weeks or longer showed greater improvements in glucose and lipids, and shorter ones in blood pressure and inflammation. [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada's taurine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada NNHPD taurine monograph (January 30, 2026), adults 18 years and older: 1.5 to 3 grams of taurine per day.

    Details and sources
  • EFSA (2009) concluded that exposure to taurine from regular energy-drink consumption (mean 125 ml/day; high 350 ml/day) is not of safety concern, and that new data confirmed a No Observed Adverse Effect Level of 1,000 mg/kg body weight per day. [5]
  • EFSA noted that its exposure estimates relied on 2003 consumption data and that current data, especially for adolescents and young adults, may need to be collected. [5]
  • The 2024 meta-analysis observed no significant adverse effects compared with controls. [3]
  • Health Canada requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [1]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
  • Canada: Health Canada's taurine monograph (oral, January 30, 2026) includes the use "Helps to support cardiovascular function." [1]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Taurine (proper name 2-aminoethanesulfonic acid) Amino acid (2-aminoethanesulfonic acid) [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming taurine itself was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). One entry names magnesium acetyl taurinate (NDI 1139 submitted 2020-01-24), and two name homotaurine compounds (NDI 50 and NDI 596), which are different substances. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of taurine was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-000 to TR-606) lists no study of taurine (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada NNHPD taurine monograph (January 30, 2026), adults 18 years and older: 1.5 to 3 grams of taurine per day. [P5]

Pregnancy and breastfeeding

  • Health Canada's taurine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [P5]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program (NIEHS). Technical Reports index (TR-000 to TR-606, checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. Health Canada, NNHPD. Monograph: Taurine (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
Sources

Sources

  1. Health Canada, NNHPD. Monograph: Taurine (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
  2. Nie Z, et al. Effects of oral taurine supplementation on cardiometabolic risk factors: a meta-analysis and systematic review of randomized clinical trials. Nutr Rev 2026;84(10):2028-2051 (PMID 41275513), 2026-10-01. pubmed.ncbi.nlm.nih.gov
  3. Tzang CC, et al. Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis. Nutr J 2024;23(1):93 (PMID 39148075), 2024-08-15. pubmed.ncbi.nlm.nih.gov
  4. Cao Q, et al. Effects of taurine supplementation on cognitive function: a systematic review and meta-analysis of randomised controlled trials. Int J Food Sci Nutr 2025;76(4):370-380 (PMID 40320621), 2025-06. pubmed.ncbi.nlm.nih.gov
  5. European Food Safety Authority. EFSA adopts opinion on two ingredients commonly used in some energy drinks (news, 12 February 2009; opinion: The use of taurine and D-glucurono-gamma-lactone as constituents of the so-called "energy" drinks), 2009-02-12. efsa.europa.eu
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.